These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11799838)

  • 1. Animal models of chronic obstructive pulmonary disease.
    Szelenyi I; Marx D
    Arzneimittelforschung; 2001; 51(12):1004-14. PubMed ID: 11799838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD: a multifactorial systemic disease.
    Huertas A; Palange P
    Ther Adv Respir Dis; 2011 Jun; 5(3):217-24. PubMed ID: 21429981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.
    Birrell MA; Wong S; Hele DJ; McCluskie K; Hardaker E; Belvisi MG
    Am J Respir Crit Care Med; 2005 Jul; 172(1):74-84. PubMed ID: 15805185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease in a new concept.
    Murărescu ED; Mitrofan EC; Mihailovici MS
    Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?
    Churg A; Sin DD; Wright JL
    Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1111-5. PubMed ID: 21685155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of COPD: lessons learned from in vivo animal models.
    Fujita M; Nakanishi Y
    Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD).
    MacNee W
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):819-23. PubMed ID: 19614601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.
    Wright JL; Churg A
    Expert Rev Respir Med; 2010 Dec; 4(6):723-34. PubMed ID: 21128748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.
    Murărescu ED; Eloae-Zugun F; Mihailovici MS
    Rom J Morphol Embryol; 2008; 49(4):495-505. PubMed ID: 19050798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Living conditions for people with COPD].
    Hem KG; Eide AH
    Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1465-8. PubMed ID: 19690596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects on pathophysiological mechanisms in COPD.
    Larsson K
    J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance.
    Stevenson CS; Birrell MA
    Pharmacol Ther; 2011 May; 130(2):93-105. PubMed ID: 21074553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
    Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aging lung and chronic obstructive pulmonary disease: similarity and difference.
    Fukuchi Y
    Proc Am Thorac Soc; 2009 Dec; 6(7):570-2. PubMed ID: 19934351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
    Fox JC; Fitzgerald MF
    Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of the chronic obstructive pulmonary disease (COPD)].
    Musil J
    Vnitr Lek; 2004 Sep; 50(9):663-7. PubMed ID: 15580897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
    Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
    Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.